The impact of hepatic steatosis on epicardial adipose tissue in obese individuals

Abstract Objectives This study aimed to evaluate the relationship between epicardial adipose tissue (EAT) thickness and hepatic steatosis in pediatric patients with obesity, exploring EAT as a potential biomarker for cardiovascular risk. Methods A retrospective analysis was conducted on children with obesity aged 10–18, including 48 patients with non-alcoholic fatty liver disease (NAFLD) and 50 age- and sex-matched controls with no liver steatosis. EAT thickness was measured using echocardiography, and liver fat was assessed via ultrasound. Correlations between EAT, metabolic parameters, and anthropometric measurements were examined. Results EAT thickness was significantly more excellent in the NAFLD group than in controls (p<0.001), with an optimal cutoff of >1.6 mm predicting hepatic steatosis with 98 % sensitivity and specificity. Positive correlations were found between EAT thickness, body mass index (BMI) Z-scores, and liver steatosis stages. Additionally, structural cardiac changes, such as increased right ventricular diastolic diameter (RVDD) and interventricular septal thickness in diastole (IVSd), were observed in the NAFLD group, suggesting early signs of cardiac remodeling. Conclusions EAT thickness may be a non-invasive biomarker for identifying cardiovascular risk in pediatric patients with obesity and NAFLD. Early detection of elevated EAT could guide interventions to reduce obesity-related cardiovascular risk in this population.

• Publication year

  2025

• Venue

  Journal of Pediatric Endocrinology & Metabolism (JPEM)

• Publication date

  2025-11-11

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1515/jpem-2025-0078PMID 41213156
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Correlation between ultrasonography and MR proton density fat fraction techniques in evaluating the severity of liver steatosis

  2024cited by this paper
• Epicardial Fat Volume Assessed by MRI in Adolescents: Associations with Obesity and Cardiovascular Risk Factors

  2024cited by this paper
• Role of epicardial adipose tissue in cardiac remodeling.

  2024cited by this paper
• Influence of Cardiovascular Risk Factors and Metabolic Syndrome on Epicardial Adipose Tissue Thickness in Rural Spanish Children and Adolescents

  2024cited by this paper
• Assessment of Epicardial Fat in Children: Its Role as a Cardiovascular Risk Factor and How It Is Influenced by Lifestyle Habits

  2024cited by this paper
• Changing from NAFLD to MASLD: Similar cumulative incidence of reflux esophagitis between NAFLD and MASLD

  2023cited by this paper
• Mechanisms Linking Metabolic-Associated Fatty Liver Disease (MAFLD) to Cardiovascular Disease

  2023influential reference
• Human Epicardial Adipose Tissue Expresses Glucose-dependent Insulinotropic Polypeptide, Glucagon and Glucagon-Like Peptide 1 Receptors as Potential Targets of Pleiotropic Therapies.

  2023cited by this paper
• Inflammation and Cardiovascular Diseases in the Elderly: The Role of Epicardial Adipose Tissue

  2022cited by this paper
• Role of obesity and blood pressure in epicardial adipose tissue thickness in children

  2022cited by this paper
• Obesity in children and adolescents: epidemiology, causes, assessment, and management

  2022cited by this paper
• Role of anatomical location, cellular phenotype and perfusion of adipose tissue in intermediary metabolism: A narrative review

  2022cited by this paper
• Role of Epicardial Adipose Tissue in Cardiovascular Diseases: A Review

  2022cited by this paper
• The association between epicardial adipose tissue and non-alcoholic fatty liver disease: A systematic review of existing human studies

  2021cited by this paper
• Non-Alcoholic Fatty Liver Disease in Children

  2021cited by this paper
• Relationship of Nonalcoholic Fatty Liver Disease and Heart Failure With Preserved Ejection Fraction

  2021cited by this paper
• Predictors of non-alcoholic fatty liver disease (NAFLD) among children with obesity

  2020cited by this paper
• Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans

  2020cited by this paper
• MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease.

  2020cited by this paper
• Association of epicardial adipose tissue with non-alcoholic fatty liver disease: a meta-analysis

  2019cited by this paper
• Epicardial adipose tissue volume is associated with non-alcoholic fatty liver disease and cardiovascular risk factors in the general population

  2018cited by this paper
• Increased severity of liver fat content and liver fibrosis in non-alcoholic fatty liver disease correlate with epicardial fat volume in type 2 diabetes: A prospective study

  2018cited by this paper
• The Association between Non-Alcoholic Fatty Liver Disease and Cardiovascular Risk in Children

  2017cited by this paper
• NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN)

  2017influential reference
• Epicardial Adipose Tissue (EAT) Thickness Is Associated with Cardiovascular and Liver Damage in Nonalcoholic Fatty Liver Disease

  2016cited by this paper
• Effects of Obesity on Cardiovascular Hemodynamics, Cardiac Morphology, and Ventricular Function

  2016cited by this paper
• Epicardial adipose tissue and signs of metabolic syndrome in children

  2016cited by this paper
• Transcardial gradient of adiponectin, interleukin-6 and tumor necrosis factor-α in overweight coronary artery disease patients.

  2015cited by this paper
• Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease.

  2000cited by this paper

• No citing papers are available for this paper.